Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

By Aguiar Aderbal  

Neurotoxicity Research, Vol. 24, Iss. 2, 2013-08 ,pp. : 280-287

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Behavioral Impairments Correlated to Neurochemical Deficits in Mice Treated with Moderate Doses of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

By Tillerson J.L.   Caudle W.M.   Reverón M.E.   Miller G.W.  

Experimental Neurology, Vol. 178, Iss. 1, 2002-11 ,pp. : 80-90

Academic Press

Access to resources Recommend Favorite

Metallothionein Inducers Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity in Mice

By Rojas Patricia   Ríos Camilo  

Neurochemical Research, Vol. 22, Iss. 1, 1997-01 ,pp. : 17-22

Springer Publishing Company

Access to resources Recommend Favorite

Spirulina maxima pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

By Chamorro Germán   Pérez-Albiter Mónica   Serrano-García Norma   Mares-Sámano José J.   Rojas Patricia  

Nutritional Neuroscience, Vol. 9, Iss. 5-6, 2006-10 ,pp. : 207-212

Maney Publishing

Access to resources Recommend Favorite

Cholinergic manipulation of motor disability and l-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets

By Jackson M.   Swart T.   Pearce R.   Jenner P.  

Journal of Neural Transmission, Vol. 121, Iss. 2, 2014-02 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite